The lower SERT immunoreactivity in the infundibular nucleus of obese participants [37], and the downregulation of SERT in the platelet membranes of morbidly obese participants [38], indicate the involvement of 5-HT in human obesity. Here, SLC6A4 is linked to obesity disorder.